Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Vir Biotechnology
VIR
$1.49B
| $4.97M | ﹤0.01% |
196,225
-43,263
| -18% | -$1.06M |
|
|
JJA
1627
DELISTED
iPath Series B Bloomberg Agriculture Subindex Total ReturnSM ETN
JJA
| $4.97M | ﹤0.01% |
195,000
| – | – |
|
|
JJS
1628
DELISTED
iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN
JJS
| $4.96M | ﹤0.01% |
83,000
| – | – |
|
1629
Acadia Pharmaceuticals
ACAD
$5.03B
| $4.95M | ﹤0.01% |
311,209
-15,838
| -5% | -$248K |
|
1630
Southwest Gas
SWX
$6.67B
| $4.94M | ﹤0.01% |
79,823
+64,335
| +415% | +$4.38M |
|
1631
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
| $4.93M | ﹤0.01% |
68,425
+2,587
| +4% | +$184K |
|
1632
CALL
Carvana
CVNA
$77.9B
| $4.93M | ﹤0.01% |
+5,203,500
| New | +$11M |
|
1633
Sensata Technologies
ST
$6.79B
| $4.93M | ﹤0.01% |
121,967
-11,328
| -8% | -$472K |
|
1634
CALL
NIO
NIO
$11.9B
| $4.92M | ﹤0.01% |
+505,000
| New | +$5.82M |
|
|
IIVI
1635
DELISTED
Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock
IIVI
| $4.91M | ﹤0.01% |
30,712
-2,437
| -7% | -$392K |
|
1636
CALL
SolarEdge
SEDG
$1.95B
| $4.9M | ﹤0.01% |
+17,300
| New | +$4.59M |
|
|
VCXB
1637
DELISTED
10X Capital Venture Acquisition Corp III
VCXB
| $4.88M | ﹤0.01% |
500,000
| – | – |
|
1638
PUT
Nu Holdings
NU
$66.9B
| $4.88M | ﹤0.01% |
+1,200,000
| New | +$5.21M |
|
1639
Installed Building Products
IBP
$6.49B
| $4.88M | ﹤0.01% |
57,056
+13,691
| +32% | +$1.15M |
|
1640
Adeia
ADEA
$3.11B
| $4.88M | ﹤0.01% |
514,792
-1,087,062
| -68% | -$11.1M |
|
|
MYOV
1641
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.88M | ﹤0.01% |
180,840
+80,746
| +81% | +$2.12M |
|
1642
CALL
DoorDash
DASH
$93.7B
| $4.87M | ﹤0.01% |
+99,800
| New | +$5.18M |
|
1643
PUT
Goodyear
GT
$1.85B
| $4.87M | ﹤0.01% |
+480,000
| New | +$5.24M |
|
1644
CALL
BJs Wholesale Club
BJ
$12.3B
| $4.86M | ﹤0.01% |
+73,500
| New | +$5.32M |
|
|
GAP
1645
CALL
The Gap Inc
GAP
$7.37B
| $4.84M | ﹤0.01% |
+429,200
| New | +$5.14M |
|
1646
Graco
GGG
$13.5B
| $4.83M | ﹤0.01% |
71,848
+55,012
| +327% | +$3.67M |
|
|
JKS
1647
CALL
JinkoSolar
JKS
$891M
| $4.83M | ﹤0.01% |
+118,200
| New | +$5.69M |
|
1648
iShares MSCI South Korea ETF
EWY
$24.1B
| $4.83M | ﹤0.01% |
85,437
+11,979
| +16% | +$656K |
|
|
LADR
1649
Ladder Capital
LADR
$1.24B
| $4.82M | ﹤0.01% |
480,097
+22,668
| +5% | +$235K |
|
1650
Novavax
NVAX
$1.31B
| $4.81M | ﹤0.01% |
467,467
+113,247
| +32% | +$2M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.